Treprostinil palmitil

Overview

Treprostinil palmitil is a long-acting inhaled pulmonary vasodilator prodrug of Treprostinil ( HY-100441 ), formulated in a lipid nanoparticle (LNP). Treprostinil palmitil can inhibit pulmonary vascular remodeling induced by Su/Hx challenge in rats. Treprostinil palmitil can induce cough. Treprostinil palmitil demonstrates a sustained presence in the lungs with reduced systemic exposure and prolonged inhibition of hypoxia-induced pulmonary vasoconstriction in vivo. Treprostinil palmitil can be studied in research for pulmonary arterial hypertension and interstitial lung disease.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Hypertension | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Endocrinology | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Prostaglandin Receptor

Product Information

• Catalog No.: HY-109163
• CAS No.: 1706528-83-7
• Molecular Formula: C39H66O5
• Molecular Weight: 614.94
• Purity: 99.62%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 9.09 mg/mL (14.78 mM); Clear solution
• Availability: In-stock

Source

Original product source